Royalty Report: Medical, Diagnostic, Cancer – Collection: 27142


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 4


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4

Primary Industries

  • Medical
  • Diagnostic
  • Cancer
  • Device
  • Disease

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 27142

License Grant
The Company acquired from a principle stockholder of the Company and Chairman of the Scientific Advisory Board, all of the issued and outstanding stock of Laser Diagnostic Instruments, Inc. whose only asset was US patent number 4,930,516 (previously defined as LDI).   A related party transaction and in connection with the acquisition of patent rights to its cancer detection technology, the Company assumed an obligation to pay royalties relating to any invention from the Company's existing patents or newly obtained patents, respectively.
Field of Use
The rights granted apply to healthcare.

IPSCIO Record ID: 3099

License Grant
In connection with the acquisition of patent rights to its cancer detection technology, the Licensee, assumed an obligation to pay the Licensor, daughter of the principle stockholder, a royalty on the gross sales derived from any equipment made, leased or sold which utilizes the concepts described in the Licensee’s cancer detection patent.  Since there has been no revenue, no amounts have been paid during the six and three months ended August 31, 2010 and 2009.
Field of Use
The rights granted apply to the healthcare industry.

IPSCIO Record ID: 6573

License Grant
An advisory agreement between the Company and a limited liability partnership, controlled by parties that are also shareholders in the Company, there is a contractual obligation to pay a royalty on a diagnostic test for Ovarian Cancer incorporating the technology and equipment developed by the Licensee,  to the Company and its subsidiaries, which includes the Company.
Field of Use
The rights granted apply to the healthcare industry.

IPSCIO Record ID: 6628

License Grant
The Licensee acquired control of Bio field, a development-stage medical technology company. The Licensee acquired all of the Company’s common shares owned by the Company’s former chairman and chief executive officer, Licensor and affiliates, pursuant to a Stock Acquisition and Voting Agreement (the Long Agreement) and a Stock Acquisition Agreement between Licensee and the Licensor.
Field of Use
The Licensee has developed an advanced medical device and associated diagnostic system, the Bio field Diagnostic System to assist in detecting breast cancer, and has secured exclusive marketing rights to products for treatment of oral and genital herpes and a diagnostic test for cervical cancer, and seeks to secure marketing rights for other complimentary products.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.